ClinicalTrials.Veeva

Menu

Use of Peppermint Oil During Screening Colonoscopy to Improve Visibility

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Enhancement of the ADR During Colonoscopy

Treatments

Other: Peppermint Oil
Other: Distilled water

Study type

Interventional

Funder types

Other

Identifiers

NCT03286764
14-006242

Details and patient eligibility

About

The investigators hypothesize that spraying peppermint oil containing L-menthol onto the colonic mucosa during colonoscopy will relax smooth muscle allowing better colonic visualization.

Enrollment

48 patients

Sex

All

Ages

50+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Screening colonoscopy
  • Age 50 years and older
  • Able to give consent

Exclusion criteria

  • No consent obtained or adult lacking capacity to consent
  • Do not reach cecum on colonoscopy
  • Renal impairment (defined as CrCl <30 ml/min)
  • Allergy to study peppermint oil solution
  • History of colon resection
  • Inflammatory bowel disease
  • Known colorectal neoplasia
  • Non-correctable coagulopathy
  • Pregnancy or lactating
  • Prisoners

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

48 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
Distilled water spray as a placebo during Colonoscopy
Treatment:
Other: Distilled water
Peppermint Oil
Experimental group
Description:
Peppermint Oil spray during Colonoscopy
Treatment:
Other: Peppermint Oil

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems